Jun 16, 2021By: Rounak Jain
Its March 2021 quarter net profit jumped three-fold to ₹105 crore from ₹33 crore a year ago. Revenue growth was relatively meek at 14 percent, increasing to ₹1,038 crore from ₹909 crore, year-on-year.
It posted a 10-time jump in net profit in the March 2021 quarter to ₹30 crore from ₹3 crore a year ago. The jump in profitability was due to reduction of discounts, marketing and other expenses.
Its subsidiary has been ordered to pay $46.2 million to Hatchtech Pty. for a skin treatment lotion. This is part of an asset acquisition agreement entered into in 2015.
Nureca, RITES, RPSG Ventures, Somany Ceramics, Asahi India Glass, Welspun Enterprises.
It has reduced the price of its iQube electric scooter by ₹11,250 after a revision in the subsidy granted under the FAME II scheme.
India’s second largest mortgage finance company reported a 5 percent decline in net profit to ₹399 crore in the March 2021 quarter, primarily due to a 36-time surge in provisions to ₹977 crore from ₹27 crore, year-on-year.
It has emerged as the lowest bidder for a ₹1,741 crore railway electrification project, undertaken by the Ministry of Railways.
Its subsidiary has partnered with Ocugen, Inc., to manufacture Covaxin for sale in the US and Canada.
It has raised ₹2,827 crore via a private placement of long-term bonds in the nature of debentures.
It has set June 18 as the record date to delist its shares from NSE and BSE.